YONG
CHANG

YONG CHANG Co., Ltd. is a specialized medical device manufacturer engaged in the development and production of medical syringes and needles based on advanced technological expertise. Since its establishment in 1999, YONG CHANG has continuously invested in research and development, delivering a wide range of medical devices that meet verified safety and quality standards and earning trust from medical professionals.

Our product portfolio includes: Class I non-sterile needles, Class II sterile needles, medical syringes, filler cannulae, Class III puncture needles, and Class IV surgical sutures. Through the production of these diverse medical devices, we have accumulated extensive manufacturing experience and technical know-how.

In 2020, YONG CHANG supplied COVID-19 vaccine syringes to the Korean government, officially demonstrating its technological capabilities. Building on this achievement, we have established automated production lines to further enhance manufacturing efficiency and product consistency. Additionally, we hold over 20 patents and 45 design and trademark registrations, enabling us to deliver differentiated products based on proprietary technologies.

YONG CHANG is certified to KGMP and ISO 13485 standards and has obtained FDA registration, ANVISA approval, and CE MDR certification. With a strong commitment to safety and quality, we will continue to make every effort to become a trusted company in the global medical device market.

Redefining the Industry Standard

The World’s First 35G Production Certification.

Our
Values

CUSTOMER
FOCUSE
Meeting Customer Expectations with Sincerity and Integrity.
RESPECT &
DIVERSITY
Strengthening Our Competitive Edge Through Continuous R&D and Product Diversification.
INITIVES &
INTEGRITY
Taking Pride in Being the Best in Our Field, Constantly Striving for Progress.
ALIGNMENT &
SYNERGY
Fostering a Culture of Harmony to Deliver the Highest Quality Results Together.

The Path
We Have

Walked

2025
July 2025
First Domestic Certification for Manufacturing AVF Needle Sets
2024
February 2024
World’s First Production and
Regulatory Approval of 35G Needles
August 2024
CE MDR Application
Submitted(Filler Cannula, Meso Needles)
December 2024
Factory Relocation & Expansion
2024 Products
2023
March 2023
Establishment of the 2nd Manufacturing Plant
2022
February 2022
Apply US of the Whole product of Yongchang
September 2022
Apply Brazil ANVISA of the Whole product of Yongchang
2021
January 2021
Manufacturing Syringes for Covid-19 Vaccine
May 2021
Achievement CE Certificate of Insulin syringe and Puncture needles
June 2021
Supply the Syringes for Covid-19 Vaccine to Korean Goverment
2020
January 2020
Start production of Spinal and Epidural needle
June 2020
Achievement CE Certificate of Sterile needles and Blunt type needles
September 2020
Start production of Insulin Syringes
2019
January 2019
Move to new buliding in Gimpo-si
February 2019
Achievement KGMP 4th Grade
2019 Syringes
2017
October 2017
Start production of Meso needle and Filler Cannula
2016
August 2016
Convert to a corporation
2011
March 2011
ISO 1st certification
2011 Certificate
2004
November 2004
Medical Device manufacturing business permission, KGMP
1999
May 1999
Establish Yongchang company